Antipsychotic and antiepileptic drugs in bipolar disorder: The importance of therapeutic drug monitoring

Current Medicinal Chemistry

Volumn 16, Issue 12, 2009, Pages 1463-1481

  Musenga, Alessandro ^a   Saracino, Maria Addolorata ^a   Sani, Gabriele ^b,c   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Centro Lucio Bini   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiepileptic agents; Atypical antipsychotics; Bipolar disorder; Pharmacodynamics; Pharmacokinetics; Therapeutic drug monitoring

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; DEPAKIN CHRONO; DRUG METABOLITE; ERYTHROMYCIN; FLUCONAZOLE; FLUOXETINE; FLUVOXAMINE; KETOCONAZOLE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PALIPERIDONE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; QUETIAPINE; RISPERIDONE; SEROQUEL XR; SEROTONIN UPTAKE INHIBITOR; TOLEP; UNCLASSIFIED DRUG; VALPROIC ACID; ZYPREXA INTRAMUSCULAR; ZYPREXA ZIDIS;

ABDOMINAL DISEASE; ABDOMINAL PAIN; AGRANULOCYTOSIS; ALOPECIA; ANALYTIC METHOD; ATAXIA; BALANCE IMPAIRMENT; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BLURRED VISION; CAPILLARY ELECTROPHORESIS; CHRONIC DISEASE; CLINICAL TRIAL; CONSTIPATION; CYCLOTHYMIA; DIPLOPIA; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG MONITORING; DRUG OVERDOSE; DRUG STRUCTURE; DRUG USE; EDEMA; EPILEPSY; EXTRAPYRAMIDAL SYMPTOM; GAS CHROMATOGRAPHY; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEADACHE; HEARTBURN; HEMORRHAGIC PANCREATITIS; HEPATITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERPROLACTINEMIA; HYPOMANIA; IRRITABILITY; MANIA; MAXIMUM PLASMA CONCENTRATION; MENTAL PATIENT; METABOLIC DISORDER; NAUSEA; ORTHOSTATIC HYPOTENSION; PATIENT CARE; QT PROLONGATION; RECURRENT DISEASE; REVIEW; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TARDIVE DYSKINESIA; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG MONITORING; HUMANS; MOLECULAR STRUCTURE;

EID: 65649140082     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709787909604     Document Type: Review

References (290)

1. Kessler, R.C.; Berglund, P.; Demler, O.; Jin, R.; Merikangas, K.R.; Walters, E.E. Arch. Gen. Psychiatry, 2005, 62, 593.
2. Szádóczky, E.; Papp, Z.; Vitrai, J.; Rihmer, Z.; Furedi, J. J. Affect Disord., 1998, 50, 153.
3. Moreno, D.H.; Andrade, L.H. J. Affect Disord., 2005, 87, 231.
4. American Psychiatric Association. Am. J. Psychiat., 2002, 159, 1.
5. Sharma, R.; Markar, H.R. J. Affect Disord., 1994, 31, 91.
6. Goodwin, F.; Jamison, K. Manic Depressive Illness, Oxford University Press: New York, 2007.
7. Koukopoulos, A. In Bipolar Psychopharmacotherapy: Caring for the Patient; Akiskal, H. and Tohen, M. Eds.; John Wiley and Sons: New York, 2006.
8. Brosen, K. Ther. Drug Monit., 1996, 18, 393.
9. Caccia, S. Curr. Opin. Investig. Drugs, 2002, 3, 1073.
10. Linnet, C. Hum. Psychopharm., 2002, 17, 233.
11. Raggi, M.A.; Mandrioli, R.; Pucci, V.; Sabbioni, C. Med. Chem. Rev., 2004, 1, 299.
12. Albers, L.J.; Ozdemir, V. Curr. Med. Chem., 2004, 11, 297.
13. Mitchell, P.B. Br. J. Clin. Pharmacol., 2001, 52, 45.
14. Fraser, A.D. In Analytical Toxicology for Clinical, Forensic and Pharmaceutical Chemists, Brandenberger, H.; Maes, R.A.A., Eds.; Walter de Gruyter: Berlin/New York, 1997; pp. 17-25.
15. Cramer, J.A.; Rosenheck, R. Psychiatr. Serv., 1998, 49, 196.
16. Xing, Q.; Qian, X.; Li, H.; Wong, S.; Wu, S.; Feng, G.; Duan, S.; Xu, M.; Gao, R.; Qin, W.; Gao, J.; Meng, J.; He, L. Int. J. Neuropsychopharmacol., 2007, 10, 631.
17. Perry, P.J.; Lund, B.C.; Sanger, T.; Beasley, C. J. Clin. Psychopharmacol., 2001, 21, 14.
18. Eilers, R. Clin. Pharmacokinet., 1995, 29, 442.
19. Hiemke, C. Eur. Arch. Psy. Clin. N., 2008, 258-S1, 21.
20. Calabrese, J.R.; Keck, P.E. Jr; Macfadden, W.; Minkwitz, M.; Ketter, T.A.; Weisler, R.H.; Cutler, A.J.; McCoy, R.; Wilson, E; Mullen, J. Am. J. Psychiat., 2005, 162, 1351.
21. Thase, M.E.; Macfadden, W.; Weisler, R.H.; Chang, W.; Paulsson, B.; Khan, A.; Calabrese, J.R.; BOLDER II Study Group. J. Clin. Psychopharmacol., 2006, 26, 600.
22. Astrazeneca press release. Available from URL: http://www astrazeneca.com/pressrelease/1160.aspx [Accessed on Apr 21, 2008]
23. Keating, G.M.; Robinson, D.M. CNS Drugs, 2007, 21, 695.
24. Peuskens, J. Eur. Neuropsychopharm., 2004, 14, S453.
25. Astrazeneca press release. Available from URL: http://www astrazeneca.com/pressrelease/5330.aspx [Accessed on Apr 21, 2008]
26. Riedel, M.; Mueller, N.; Strassnig, M.; Spellman, I.; Severus, E.; Moeller, H.J. Neurop. Dis. Treat., 2007, 3, 219.
27. Nemeroff, C.B.; Kinkead, B.; Goldstein, J. J. Clin. Psychiat., 2002, 63, 5.
28. Richelson, E.; Souder, T. Life Sci., 2000, 68, 29.
29. Goldstein, J.M. Drugs Today, 1999, 35, 193.
30. Yatham, L.N.; Goldstein, J.M.; Vieta, E.; Bowden, C.L.; Grunze, H.; Post, R.M.; Suppes, T.; Calabrese. J.R.; J. Clin. Psychiat., 2005, 66, 40.
31. Goldstein, J.M.; Christoph, G.; Grimm, S.; Liu, J.W.; Widzowski, D.; Brecher, M. Unique mechanism of action for the antidepressant properties of the atypical antipsychotic quetiapine. 20th European College of Neuropsychopharmacology Congress, Vienna, October 13-17, 2007.
32. Jensen, N.H.; Rodriguiz, R.M.; Caron, M.G.; Wetsel, W.C.; Rothman, R.B.; Roth. B.L. Neuropsychopharmacol., 2008, 33, 2303.
33. Dunner, D.L. Bipolar Disord. 2005, 7, 307.
34. Keating, G.M.; Robinson, D.M. Drugs, 2007, 67, 1077.
35. Adler, C.; Fleck, D.; Brecher, M.; Strakowski, S. J. Affect. Disord., 2007, 100, S15.
36. Martindale - The Complete Drug Reference, 34th Edition, Sweetman, S.C., Ed., Pharmaceutical Press: London, 2004; p. 718.
37. Guo, J.J.; Keck, P.E. Jr.; Corey-Lisle, P.K.; Li, H.; Jiang, D.; Jang, R.; L'Italien, G.J. Pharmacotherapy, 2007, 27, 27.
38. Pollak, P.; Zbuk, K. Clin. Pharmacol. Ther., 2000, 68, 92.
39. Shahzad, S.; Suleman, M.I.; Shahab, H.; Mazour, I.; Kaur, A.; Rudzinskiy, P.; Lippmann, S.; Psychosomatics, 2002, 43, 354.
40. AstraZeneca. Seroquel® (quetiapine fumarate) tablets: Prescribing information. Available from URL: http://www.seroquel.com [Accessed Apr 21, 2008]
41. Valibhai, F.; Phan, N.B.; Still, D.J.; True, J. Am. J. Psychiatry, 2001, 158, 966.
42. DeVane, C.L.; Nemeroff, C.B. Clin. Pharmacokinet., 2001, 40, 509.
43. Caccia, S. Clin. Pharmacokinet., 2000, 38, 393.
44. Raggi, M.A.; Mandrioli, R.; Sabbioni, C.; Pucci, V. Curr. Med. Chem., 2004, 11, 279.
45. Grimm, S.W.; Richtand, N.M.; Winter, H.R.; Stams, K.R.; Reele, S.B. Brit. J. Clin. Pharmaco., 2005, 61, 58.
46. Castberg, I.; Skogvoll, E.; Spigset, O. J. Clin. Psychiat., 2007, 68, 1540.
47. Wong, Y.W.J.; Yeh, C.; Thyrum, P.T. J. Clin. Psychopharmacol., 2001, 21, 89.
48. Fitzgerald, B.J.; Okos, A.J. Pharmacotherapy, 2002, 22, 1500.
49. Aichhorna, W.; Marksteinera, J.; Walcha, T.; Zernigb, G.; Sariab, A.; Kemmlera, G. Int. Clin. Psychopharm., 2006, 21, 81.
50. Winter, H.R.; DeVane, C.L.; Figueroa, C.; Ennis, D.J.; Hamer-Maansson, J.E.; Davis, P.C.; Smith, M.A. Hum. Psychopharmacol., 2007, 22, 469.
51. Winter, H.R.; Earley, W.R.; Hamer-Maansson, J.E.; Davis, P.C.; Smith, M.A.; J. Child Adol. Psychop., 2008, 18, 81.
52. Parker, D.R.; McIntyre, I.M. J. Anal. Toxicol., 2005, 29, 407.
53. Belal, F.; Elbrashy, A.; Eid, M.; Nasr, J.J. J. Liq. Chromatogr. R. T., 2008, 31, 1283.
54. Rampono, J.; Kristensen, J.H.; Ilett, K.; Hackett, L.P.; Kohan, R. Ann. Pharmacother., 2007, 41, 711.
55. Mercolini, L.; Grillo, M.; Bartoletti, C.; Boncompagni, G.; Raggi, M.A. Anal. Bioanal. Chem., 2007, 388, 235.
56. Saracino, M.A.; Mercolini, L.; Flotta, G.; Albers, L.J.; Merli, R.; Raggi, M.A. J. Chromatogr. B, 2006, 843, 227.
57. Sachse, J.; Koeller, J.; Haertter, S.; Hiemke, C. J. Chromatogr. B, 2006, 830, 342.
58. Frahnert, C.; Rao, M.L.; Grasmader, K. J. Chromatogr. B, 2003, 794, 35.
59. Mandrioli, R.; Fanali, S.; Ferranti, A.; Raggi, M.A. J. Pharmaceut. Biomed., 2002, 30, 969.
60. Barrett, B.; Holcapek, M.; Huclova, J.; Borek-Dohalsky, V.; Fejt, P.; Nemec, B.; Jelinek, I. J. Pharmaceut. Biomed., 2007, 44, 498.
61. Lin, S.N.; Chang, Y.; Moody, D.E.; Foltz, R.L. J. Anal. Toxicol., 2004, 28, 443.
62. Li, K.Y.; Li, X.; Cheng, Z.N.; Peng, W.X.; Zhang, B.K.; Li, H.D. Acta Pharmacol. Sin., 2004, 25, 390.
63. Zhou, Z.; Li, X.; Li, K.; Xie, Z.; Cheng, Z.; Peng, W.; Wang, F.; Zhu, R.; Li, H. J. Chromatogr. B, 2004, 802, 257.
64. Li, K.Y.; Cheng, Z.N.; Li, X.; Bai, X.L.; Zhang, B.K.; Wang, F.; Li, H.D. Acta Pharmacol. Sin., 2004, 25, 110.
65. Kirchherr, H.; Kuehn-Velten, W. N. J. Chromatogr. B, 2006, 843, 100.
66. Davis, P.C.; Wong, J.; Gefvert, O. J. Pharmaceut. Biomed., 1999, 20, 271.
67. Anderson, D.T.; Fritz, L.K. J. Anal. Toxicol., 2000, 24, 300.
68. Flammia, D.D.; Valouch, T.; Venuti, S. J. Anal. Toxicol., 2006, 30, 287.
69. Wise, S.; Jenkins, A.J. J. Forensic Sci., 2005, 50, 209.
70. Pullen, R.H.; Palermo, K.M.; Curtis, M.A. J. Chromatogr., 1992, 573, 49.
71. Pucci, V.; Mandrioli, R.; Ferranti, A.; Furlanetto, S.; Raggi, M.A. J. Pharmaceut. Biomed., 2003, 32, 1037.
72. Conley, R.R. Kelly, D.L. Med. Chem. Rev., 2005, 2, 177.
73. Martindale - The Complete Drug Reference, 34th Edition, Sweetman, S.C., Ed., Pharmaceutical Press: London, 2004; p. 710.
74. Lilly®: Facts About Zyprexar (olanzapine) Available from URL: http://www.lilly.com/news/pdf/zyprexa_factsheet_final_110707.pdf [Accessed on May 13, 2008]
75. Mitchell, M.; Riesenberg, R.; Bari, M.A.; Marquez, E.; Kurtz, D.; Falk, D.; Hardy, T.; Taylor, C.C.; Mitchell, C.P.; Cavazzoni, P. Clin. Ther., 2006, 28, 881.
76. Lilly. ZYPREXA® (Olanzapine Tablets), ZYPREXA® ZYDIS® (Olanzapine Orally Disintegrating Tablets), ZYPREXA® (Intra-Muscular Olanzapine for Injection). Available from URL: http://pi.lilly.com/us/ zyprexa-pi.pdf [Accessed on Jun 25, 2008]
77. Bymaster, F.P.; Calligaro, D.O.; Falcone, J.F. Neuropsychopharmacol., 1996, 14, 87.
78. Capuano, B.; Crosby, I.T.; Lloyd, E.J.; Taylor, D.A. Aust. J. Chem., 2002, 55, 565.
79. Raggi, M.A. Curr. Med. Chem., 2002, 9, 1397.
80. Bonanno, D.G.; Davydov, L.; Botts, S.R. Ann. Pharmacother., 2001, 35, 563.
81. Callaghan, J.T.; Bergstrom, R.F.; Ptak, L.R.; Beasley, C.M. Clin. Pharmacokinet., 1999, 37, 177.
82. Calligaro, D.O.; Fairhurst, J.; Hotten, T.M.; Moore, N.A.; Tupper, D.E. Bioorg. Med. Chem. Lett., 1997, 7, 25.
83. Carrillo, J.A.; Herraiz, A.G.; Ramos, S.I.; Gervasini, G.; Vizcaino, S.; Benitez, J. J. Clin. Psychopharmacol., 2003, 23, 119.
84. Albers, L.J.; Ozdemir, V.; Marder, S.R.; Raggi, M.A.; Aravagiri, M.; Endrenyi, L.; Reist, C. J. Clin. Psychopharmacol., 2005, 25, 170.
85. Olesen, O.V.; Linnet, K. Ther. Drug Monit., 1999, 21, 87.
86. Robertson, M.D.; Mc Mullin, M.M. J. Forensic Sci., 2000, 45, 418.
87. Dusci, L.J.; Hackett, L.P.; Fellows, L.M.; Ilett, K.F. J. Chromatogr. B., 2002, 773, 191.
88. D'Arrigo, C.; Migliardi, G.; Santoro, V.; Spina, E. Ther. Drug Monit., 2006, 28, 388.
89. Jasinska, A.; Starczewska, B.; Polkowska, M.; Puzanowska-Tarasiewicz, H. Anal. Lett., 2005, 38, 815.
90. Boulton, D.W.; Markowitz, J.S.; DeVane, C.L. J. Chromatogr. B., 2001, 759, 319.
91. Olesen, O.V.; Linnet, K. J. Chromatogr. B, 1998, 714, 309.
92. Llorca, P.M.; Coudore, F.; Corpelet, C.; Buyens, A.; Hoareau, M.; Eschalier, A. Clin. Chem., 2001, 47, 1719.
93. Zhang, G.; Terry, A.V. Jr.; Bartlett, M.G. J. Chromatogr. B, 2007, 858, 276.
94. Nirogi, R.V.S.; Kandikere, V.N.; Shukla, M.; Mudigonda, K.; Maurya, S.; Boosi, R.; Yerramilli, A. J. Pharmaceut. Biomed., 2006, 41, 935.
95. Zhou, Z.; Li, X.; Li, K.; Xie, Z.; Cheng, P.W.; Wang, F.; Zhu, R.; Li, H. J. Chromatogr. B, 2004, 802, 257.
96. Gervasini, G.; Vizcaino, S.; Herraiz, A.G.; Benitez, J.; Carrillo, J.A. Clin. Chem., 2003, 49, 2088.
97. Kollroser, M.; Schober, C. Rapid. Commun. Mass Sp., 2002, 6, 1266.
98. Berna, M.; Ackermann, B.; Ruterbories, K.; Glass, S. J. Chromatogr. B., 2002, 767, 163.
99. Bogusz, M.J.; Kruger, K.D.; Maier, R.D.; Erkwoh, R.; Tuchtenhagen, F. J. Chromatogr. B., 1999, 732, 257.
100. Berna, M.; Shugert, R.; Mullen, J, J. Mass Spectrom., 1998, 33, 1003.
101. Catlow, J.T.; Barton, R.D.; Clemens, M.; Gillespie, T.A.; Goodwin, M.; Swanson, S.P. J. Chromatogr. B, 1995, 668, 85.
102. Aravagiri, M.; Ames, D.; Wirshing, W.C.; Marder, S.R. Ther. Drug Monit., 1997, 19, 307.
103. Raggi, M.A.; Casamenti, G., Mandrioli, R.; Volterra, V. J. Chromatogr. B, 2001, 750, 137.
104. Raggi, M.A.; Mandrioli, R., Sabbioni, C., Ghedini, N.; Fanali, S.; Volterra, V. Chromatographia, 2001, 54, 203.
105. Theisen, F.M.; Haberhausen, M.; Schulz, E.; Fleischhaker, C.; Clement, H-W.; Heinzel-Gutenbrunner, M.; Remschmidt, H. Ther. Drug Monit., 2006, 28, 750.
106. Sabbioni, C.; Saracino, M.A.; Mandrioli, R.; Albers, L.; Boncompagni, G.; Raggi, M.A. Anal. Chim. Acta. 2004, 516, 111.
107. Saracino, M.A.; Koukopoulos, A.; Sani, G.; Amore, M.; Raggi, M.A. Ther. Drug Monit., 2007, 6, 773.
108. Ulrich, S. Ther. Drug Monit., 2005, 27, 463.
109. McElroy, S.L.; Keck, P.E. Jr. Biol. Psychiat., 2000, 48, 539.
110. Tohen, M.; Zarate, C.A. Jr. J. Clin. Psychiat., 1998, 59, 38.
111. Raggi, M.A. Curr. Med. Chem., 2002, 9, 1397.
112. U.S. Food and Drug Administration. Available from URL: http://www.fda.gov/CDER/DRUG/infopage/antipsychotics/ default.htm [Accessed on July 02, 2008]
113. Gutierrez, R.; Lee, P.I.D.; Huang, M.-L.; Woestenborghs, R.; Pharmacotherapy, 1997, 17, 599.
114. Janssen. RISPERDAL® (Risperidone Tablets/Oral Solution), RISPERDAL® M-TAB™ (Risperidone Orally Disintegrating Tablets). Available from URL: http://www.janssen.com/janssen/shared/pi/ risperdal.pdf. [Accessed on July 02, 2008]
115. Schotte, A.; Janssen, P.F.M.; Gommeren, W.; Luyten, W.H.M.L.; Van Gompel, P.; Lesage, A.S.; De Loore, K.; Leysen, J.E. Psychopharmacol., 1996, 124, 57.
116. Megens, A.A.H.P.; Awouters, F.H.L.; Schotte, A.; Meert, T.F.; Dugovic, C.; Niemegeers, C.J.E.; Leysen, J.E. Psychopharmacol., 1994, 114, 9.
117. Yoon, D.J. Clin. Psychopharmacol. Neurosci., 2003, 1, 147.
118. Knable, M.B.; Heinz, A.; Raedler, T.; Weinberger, D.R. Psychiat. Res., 1997, 75, 91.
119. Brunelleschi, S.; Zeppegno, P.; Risso, F.; Cattaneo, C.I.; Torre, E. Pharmacol. Res., 2003, 48, 405.
120. Martindale - The Complete Drug Reference, 34th Edition, Sweetman, S.C., Ed., Pharmaceutical Press: London, 2005; p. 719.
121. Yerrabolu, M.; Prabhudesai, S.; Tawam, M.; Winter, L.; Kamalesh, M. Heart Dis., 2000, 2, 10.
122. Acri, A.A.; Henretig, F.M. Am. J. Emerg. Med., 1998, 16, 498.
123. Cheslik, T.A.; Erramouspe, J.; Ann. Pharmacother., 1996, 30, 360.
124. Borison, R.L.; Diamond, B.; Pathiraja, A.; Meibach, R.C. Psychopharmacol. Bull., 1994, 30, 193.
125. Mannens, G.; Meuldermans, W.; Snoeck, E.; Heykants, J. Psychopharmacology, 1994, 114, 566.
126. Foroutan, S.M.; Zarghi, A.; Shafaati, A.; Khoddam, A. Iranian J. Pharm. Res., 2006, 5, 37.
127. LLerena, A.; Berecz, R.; Dorado, P.; Sanz de la Garza, C.; Norberto, M.J.; Caceres, M.; Gutierrez, J.R. J. Chromatogr. B, 2003, 783, 213.
128. Avenoso, A.; Facciolà, G.; Salemi, M.; Spina, E. J. Chromatogr. B, 2000, 746, 173.
129. Nagasaki, T.; Ohkubo, T.; Sugawara, K.; Yasui, N.; Furukori, H.; Kaneko, S. J. Pharmaceut. Biomed., 1999, 19, 595.
130. Olesen, O.V.; Linnet, K. J. Chromatogr. B, 1998, 714, 309.
131. Olesen, O.V.; Linnet, K. J. Chromatogr. B, 1997, 698, 209.
132. Shen, Y. L.; Wu, H. L.; Ko, W. K.; Wu, S. M. Anal. Chim. Acta, 2002, 460, 201.
133. Raggi, M.A.; Bugamelli, F.; Sabbioni, C.; Saracino, M.A.; Petio, C. J. Sep. Sci., 2005, 28, 245.
134. Balant-Gorgia, A.E.; Gex-Fabry, M.; Genet, C.; Balant, L.P. Ther. Drug Monit., 1999, 21, 105.
135. Aravagiri, M.; Marder, S.R.; Van Putten, T.; Midha, K.K. J. Pharm. Sci., 1993, 82, 447.
136. Aravagiri, M.; Marder, S.R.; Wirshing, D.; Wirshing, W.C. Pharmacopsychiatry, 1998, 31, 102.
137. Le Moing, J.P.; Edouard, S.; Levron, J.C. J. Chromatogr. B, 1993, 614, 333.
138. Schatz, D.S.; Saria, A. Pharmacology, 2000, 60, 51.
139. Aravagiri, M.; Marder, S.R. J. Mass Spectrom., 2000, 35, 718.
140. McClean, S.; O'Kane, E.J.; Smyth, W.F. J. Chromatogr. B, 2000, 740, 141.
141. Moody, D.E.; Laycock, J.D.; Huang, W.; Foltz, R.L., J. Anal. Toxicol., 2004, 28, 494.
142. Zhang, L.; Jiao, Z.; Yao, Z.; Zhong, Y.; Zhong, M.; Yu, Y. Chromatographia, 2005, 61, 245.
143. Bhatt, J.; Subbaiah, G.; Singh, S. Rapid Commun. Mass Sp., 2006, 20, 2109.
144. Zhang, G.; Terry, A.V.Jr.; Bartlett, M.G. Rapid Commun. Mass Sp., 2007, 21, 920.
145. Cabovska, B.; Cox, S. L.; Vinks, A. A. J. Chromatogr. B, 2007, 852, 497.
146. Bristol-Myers Squibb Company press release. Available from URL: http://newsroom.bms.com/article_display.cfm?article_id=5324 [Accessed on Jul 1, 2008]
147. Company press release. Available from URL: http://newsroom.bms.com/ article_display.cfm?article_id=5325 [Accessed on Jul 1, 2008]
148. Bristol-Myers Squibb Abilify®: Prescribing information. Available from URL: http://packageinserts.bms.com/pi/pi_abilify.pdf [Accessed on Jul 1, 2008]
149. Green, B. Curr. Med. Res. Opin., 2004, 20, 207.
150. Wood, M.; Reavill, C. Expert Opin. Investig. Drugs, 2007, 16, 771.
151. Davies, M.A.; Sheffler, D.J.; Roth, B.L. CNS Drug Rev., 2004, 10, 317.
152. Swainston, H.T.; Perry, C.M. Drugs, 2004, 64, 1715.
153. Stahl, S.M. J. Clin. Psychiat., 2001, 62, 923.
154. McIntyre, R.S.; Soczynska, J.K.; Woldeyohannes, H.O.; Miranda, A.; Konarski, J.Z. Expert Opin. Pharmacother., 2007, 8, 1001.
155. Marder, S.R.; McQuade, R.D.; Stock, E.; Kaplita, S.; Marcus, R.; Safferman, A.Z.; Saha, A.; Ali, M.; Iwamoto, T. Schizophr. Res., 2003, 61, 123.
156. Newcomer, J.W. CNS Drugs, 2005, 19, 1.
157. Gao, K.; Ganocy, S.J.; Gajwani, P.; Muzina, D.J.; Kemp, D.E.; Calabrese, J.R. J. Clin. Psychiatry, 2008, 69, 302.
158. Urichuk, L.; Prior, T.I.; Dursun, S.; Baker, G. Curr. Drug Metab., 2008, 9, 410.
159. Citrome, L.; Macher, J.P.; Salazar, D.E.; Mallikaarjun, S.; Boulton, D.W. J. Clin. Psychopharmacol., 2007, 27, 279.
160. Molden, E.; Lunde, H.; Lunder, N.; Refsum, H. Ther. Drug Monit., 2006, 28, 744.
161. Kubo, M.; Mizooku, Y.; Hirao, Y.; Osumi, T. J. Chromatogr. B, 2005, 822, 294.
162. Zuo, X.C.; Wang, F.; Xu, P.; Zhu, R.H.; Li, H.D. Chromatographia, 2006, 64, 387.
163. Kirchherr, H.; Kuehn-Velten, W.N. J. Chromatogr. B, 2006, 843, 100.
164. Kirschbaum, K.M.; Mueller, M.J.; Zernig, G.; Saria, A.; Mobascher, A.; Malevani, J.; Hiemke, C. Clin. Chem., 2005, 51, 1718.
165. Huang, H.H.; Liu, C.H.; Lan, T.H.; Hu, T.M.; Chiu, H.J.; Wu, Y.C.; Tseng, Y.L. J. Chromatogr. B, 2007, 856, 57.
166. Musenga, A.; Saracino, M.A.; Spinelli, D.; Rizzato, E.; Boncompagni, G.; Kenndler, E.; Raggi, M.A. Anal. Chim. Acta, 2008, 612, 204.
167. Bartoli, A.; Guerrini, R.; Belmonte, A.; Alessandri, M.G.; Gatti, G.; Perucca, E. Ther. Drug Monit., 1997, 19, 252.
168. Lamictal®: Prescribing information. Available from URL: http://us.gsk.com/products/assets/us_lamictal.pdf [Accessed June 13, 2008]
169. Ketter, T.A.; Post, R.M.; Theodore, W.H. Neurology., 1999, 53, 53.
170. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiat, 2002, 159, 1.
171. Calabrese, J.R.; Huffman, R.F.; White, R.L.; Edwards, S.; Thompson, T.R.; Ascher, J.A.; Monaghan, E.T.; Leadbetter, R.A. Bipolar Disord., 2008, 10, 323.
172. Martindale - The Complete Drug Reference, 34th Edition, Sweetman, S.C., Ed., Pharmaceutical Press: London, 2005; p. 363.
173. Meldrum, B.S. Epilepsia, 1996, 37, 4.
174. Ketter, T.A.; Manji, H.K.; Post, R.M. J. Clin. Psychopharm., 2003, 23, 484.
175. Faught, E.; Morris, G.; Jacobson, M.; French, J.; Harden, C.; Montouris, G.; Rosenfeld, W. Epilepsia, 1999, 40, 1135.
176. Ramsay, R.E.; Pellock, J.M.; Garnett, W.R.; Sanchez, R.M.; Valakas, A.M.; Wargin, W.A.; Lai, A.A.; Hubbell, J.; Chern, W.H.; Allsup, T. Epilepsy Res., 1991, 10, 191.
177. Rambeck, B.; Wolf, P. Clin. Pharmacokinet., 1993, 25, 433.
178. Chan, V.; Morris, R.G.; Ilett, K.F.; Tett, S.E. Ther. Drug Monitor., 2001, 23, 630.
179. Hussein, Z.; Posner, J. Br. J. Clin. Pharmacol., 1997, 43, 457.
180. Patsalos, P.N. Ann. Clin Biochem., 1999, 36, 10.
181. Sabers, A.; Oehman, I.; Christensen, J.; Tomson, T. Neurology, 2003, 61, 570.
182. Sidhu, J.; Job, S.; Singh, S.; Philipson, R. Br. J. Clin. Pharmacol., 2006, 61, 191.
183. Ohman, I.; Vitols, S.; Tomson, T. Epilepsia, 2000, 41, 709.
184. Pennell, P.B.; Newport, D.J.; Stowe, Z.N.; Helmers, S.L.; Montgomery, J.Q.; Henry, T.R. Neurology, 2004, 62, 292.
185. Cheng, C.L.; Chou, C.H.; Hu, O.Y.P. J. Chromatogr. B, 2005, 817, 199.
186. Contin, M.; Balboni, M.; Callegati, E.; Candela, C.; Albani, F.; Riva, R.; Baruzzi, A. J. Chromatogr. B, 2005, 828, 113.
187. Patil, K.; Bodhankar, S.L. J. Pharmaceut. Biomed., 2005, 39, 181.
188. Franceschi, L.; Furlanut, M. Pharmacol. Res., 2005, 51, 297.
189. Bompadre, S.; Tagliabracci, A.; Battino, M.; Giorgetti, R. J. Chromatogr. B, 2008, 863, 177.
190. Greiner-Sosanko, E.; Lower, D.R.; Virji, M.A.; Krasowski, M.D. Biomed. Chromatogr., 2007, 21, 225.
191. Dumortier, G.; Pons, D.; Zerrouk, A.; Januel, D.; Saba, G.; Degrassat, K. J. Liq. Chromatogr. R. T., 2001, 24, 3171.
192. Frey, H.O.; Kinkeldei, J.; Quast, M. Labor. Medizin, 1994, 17, 166.
193. Vermeij, T.A.C.; Edelbroek, P.M. J. Chromatogr. B, 2007, 857, 40.
194. Bugamelli, F.; Sabbioni, C.; Mandrioli, R.; Kenndler, E.; Albani, F.; Raggi, M.A. Anal. Chim. Acta, 2002, 472, 1.
195. Saracino, M.A.; Bugamelli, F.; Conti, M.; Amore, M.; Raggi, M.A. J. Sep. Sci., 2007, 30, 2249.
196. Beck, O.; Oehman, I.; Nordgren, H.K. Ther. Drug Monit., 2006, 28, 603.
197. Gergov, M.; Weinmann, W.; Meriluoto, J.; Uusitalo, J.; Ojanperae, I. Rapid Commun. Mass Sp., 2004, 18, 1039.
198. Gergov, M.; Ojanpera, I.; Vuori, E. J. Chromatogr. B, 2003, 795, 41.
199. Greiner-Sosanko, E.; Giannoutsos, S.; Lower, D.R.; Virji, M.A.; Krasowski, M.D. J. Chromatogr. Sci., 2007, 45, 616.
200. Queiroz, M.E.C.; Silva, S.M.; Carvalho, D.; Lancas, F.M. J. Chromatogr. Sci., 2002, 40, 219.
201. Queiroz, M.E.C.; Carrilho, E.; Carvalho, D.; Lancas, F.M. Chromatographia, 2001, 53, 485.
202. Zheng, J.; Jann, M.W.; Hon, Y.Y.; Shamsi, S.A. Electrophoresis, 2004, 25, 2033.
203. Theurillat, R.; Kuhn, M.; Thormann, W. J. Chromatogr. A, 2002, 979, 353.
204. Thormann, W.; Theurillat, R.; Wind, M.; Kuldvee, R. J. Chromatogr. A, 2001, 924, 429.
205. Pucci, V.; Bugamelli, F.; Baccini, C.; Raggi, M.A. Electrophoresis, 2005, 26, 935.
206. Cooper, J.D.H.; Shearsby, N.J.; Taylor, J.E.; Fook Sheung, C.T.T. J. Chromatogr. B., 1997, 702, 227.
207. Thomas, R.H. Psychopharmacol. Bull., 2003, 37, 5.
208. Lennkh, C.; Simhandl, C. Int. Clin. Psychopharmacol., 2000, 15, 1.
209. Martindale - The Complete Drug Reference, 34th Edition, Sweetman, S.C., Ed., Pharmaceutical Press: London, 2005; p. 380.
210. Steering Committee. J. Clin. Psychiatry, 1996, 57, 3.
211. Lagacea, D.C.; O'Brienb, W.T.; Gurvichb, N.; Nachtigala, M.W.; Klein, P.S. Clin. Neurosci. Res., 2004, 4, 215.
212. McLean, M.J.; Macdonald, R.L. J. Pharmacol. Exp. Ther., 1986, 237, 1001.
213. Albus, H.; Williamson, R. Epilepsia, 1998, 39, 124.
214. Macdonald, R.L.; Kelly, K.M. Epilepsia, 1994, 35, 41.
215. Bourina, M.; Prica, C. Neurosci. Biobehav. R., 2007, 31, 963.
216. Löscher, W. Prog. Neurobiol., 1999, 58, 31.
217. Manji, H.K.; Moore, G.J.; Chen, G. Br. J. Psychiatry, 2001, 178, 107.
218. Rosenberg, G. Cell. Mol. Life Sci., 2007, 64, 2090.
219. Davis, R.; Peters, D.H.; McTavish, D. Drugs, 1994, 47, 332.
220. Chang, T.K.; Abbott, F.S. Drug Metab. Rev., 2006, 38, 627.
221. Evans, R.J.; Miranda, R.N.; Jordan, J.; Krolikowski, F.J. Am. J. Forensic Med. Pathol., 1995, 16, 62.
222. Gerstner, T.; Büsing, D.; Bell, N.; Longin, E.; Kasper, J.-M.; Klostermann, W.; Hebing, B.; Hanefeld, F.; Eckel, U.; Hoffmann, R.; Bettendorf, U.; Weidner, B.; Wiemer-Kruel, A.; Brockmann, K.; Neumann, F.-W.; Sandrieser, T.; Wolff, M.; König, S. J. Gastroenterol., 2007, 42, 39.
223. Scott, J.; Pope, M. Am. J. Psychiat, 2002, 159, 1927.
224. Liu, H.; Montoya, J.L.; Forman, L.J.; Eggers, C.M.; Barham, C.F.; Delgado, M. Ther. Drug Monit., 1992, 14, 513.
225. Silva, M.F.B.; Aires, C.C.P.; Luis, P.M.B.; Ruiter, J.P.N.; Ijlst, L.; Duran, M.; Wanders, R.J.A.; Tavares de Almeida, I. J. Inherit. Metab. Dis., 2008, 31, 205.
226. Loscher, W. CNS Drugs, 2002, 16, 669.
227. Cheng, H.; Liu, Z.; Blum, W.; Byrd, J.C.; Klisovic, R.; Grever, M.R.; Marcucci, G.; Chan, K.K. J. Chromatogr. B, 2007, 850, 206.
228. Jain, D.S.; Subbaiah, G.; Sanyal, M.; Shrivastav, P. Talanta, 2007, 72, 80.
229. Zhong, Y.; Jiao, Z.; Yu, Y. Biomed. Chromatogr., 2006, 20, 319.
230. Lin, M.-C.; Kou, H.-S.; Chen, C.-C.; Wu, S.-M.; Wu, H.-L. J. Chromatogr. B, 2004, 810, 169.
231. Rompotis, S.; Parissi-Poulou, M.; Gikas, E.; Kazanis, M.; Vavayannis, A.; Panderi, I. J. Liq. Chromatogr. R. T., 2002, 25, 2833.
232. Hara, S.; Kamura, M.; Inoue, K.; Fukuzawa, M.; Ono, N.; Kuroda, T. Biol. Pharm. Bull., 1999, 22, 975.
233. Amini, H.; Javan, M.; Ahmadiani, A. J. Chromatography. B, 2006, 830, 368.
234. Kishore, P.; Kumar, V.; Rajani; S.V.; Krishna, D.R. Pharmazie, 2003, 58, 378.
235. Lucarelli, C.; Villa, P.; Lombaradi, E.; Prandini, P.; Brega, A. Chromatographia, 1992, 733, 37.
236. Liu, H.; Forman, L.J.; Montoya, J.; Eggers, C.; Barham, C.; Delgado, M. J. Chromatogr., 1992, 576, 163.
237. Belin, G.K.; Kraehenbuehl, S.; Hauser, P.C. J. Chromatogr. B, 2007, 847, 205.
238. Jin, L.J.; Wang, T.; Li, S.F.Y. Electrophoresis, 1999, 20, 1856.
239. Pucci, V.; Mandrioli, R.; Raggi, M.A. Electrophoresis, 2003, 24, 2076.
240. Miljkovic, B.; Pokrajac, M.; Varagic, V.; Levic, Z. Int. J. Clin. Pharm. Res., 1991, 11, 137.
241. Romanyshyn, L.A.; Wagner, M.C.; Wichmann, J.K.; Kucharczyk, N.; Sofia, R.D. Epilepsia, 1994, 35, 406.
242. Yu, H.-Y.; Shih, M.-C. Ther. Drug Monit., 1996, 18, 107.
243. Deng, C.; Li, N.; Ji, J.; Yang, B.; Duan, G.; Zhang, X. Rapid Commun. Mass Sp., 2006, 20, 1281.
244. Gaetani, E.; Laureri, C.F.; Vitto, M. J. Pharmaceut. Biomed., 1992, 10, 193.
245. Katayama, H.; Watanabe, M.; Yoshitomi, H.; Yoshida, H.; Kimoto, H.; Kamiya, A.; Hayashi, T.; Akimura, T. Biol. Pharm. Bull., 1998, 21, 304.
246. Nakajima, M.; Yamato, S.; Shimada, K.; Sato, S.; Kitagawa, S.; Honda, A.; Miyamoto, J.; Shoda, J.; Ohya, M.; Miyazaki, H. Ther. Drug Monit., 2000, 22, 716.
247. Sachdeo, R.; Beydoun, A.; Schachter, S.; Vazquez, B.; Schaul, N.; Mesenbrink, P.; Kramer, L.; D'Souza, J. Neurology, 2001, 57, 864.
248. Beydoun, A.; Kutluay, E. Expert Opin. Pharmacother., 2002, 3, 59.
249. Popova, E.; Leighton, C.; Bernabarre, A.; Bernardo, M.; Vieta, E. Expert Review of Neurotherapeutics, 2007, 7, 617.
250. Tecoma, E.S. Epilepsia, 1999, 40, 37.
251. Lloyd, P.; Flesch, G.; Dieterle, W. Epilepsia, 1994, 35, SIO.
252. Pratoomsri, W.; Yatham, L.N.; Bond, D.J.; Lam, R.W.; Sohn, C.H. Can. J. Psychiatry., 2006, 51, 540.
253. Kalis, M.M.; Huff, N.A. Clin. Ther., 2001, 23, 680.
254. White, H.S. Epilepsia, 1999, 40, 2.
255. Faigle, J.W.; Menge, G.P. Behav. Neurol., 1990, 3, 21.
256. Viola, M.S.; Bercellini, M.A.; Saidon, P.; Rubio, M.C. Medicina-Buenos Aire, 2000, 60, 914.
257. Gonzalez-Esquivel, D.F.; Ortega-Gavilan, M.; Alcantara-Lopez, G.; Jung-Cook, H. Arch. Med. Res., 2000, 31, 202.
258. Larkin, J.G.; McKee, P.J.W.; Forrest, G.; Beastall, G.H.; Park, B.K.; Lowrie, J.I.; Lloyd, P.; Brodie, M.J. Brit. J. Clin. Pharmaco., 1991, 31, 65.
259. Tartara, A.; Galimberti, C.A.; Manni, R.; Morini, R.; Limido, G.; Gatti, G.; Bartoli, A.; Strada, G.; Perucca, E. Brit. J. Clin. Pharmaco., 1993, 36, 366.
260. Pienimäki, P.; Fuchs, S.; Isojärvi, J.; Vähäkangas, K. J. Chromatogr. B, 1995, 673, 97.
261. Grant, S.M.; Faulds, D. Drugs, 1992, 43, 873.
262. Myllinen, P.; Pienimäki, P.; Raunio, H.; Vahakangas, K. Hum. Exp. Toxicol., 1998, 17, 668.
263. Glauser, T.A. Neurology, 2000, 55, 30.
264. Glauser, T.A.; Nigro, M.; Sachdeo, R.; Pasteris, L.A.; Weinstein, S.; Abou-Khalil, B.; Frank, L.M.; Grinspan, A.; Guarino, T.; Bettis, D.; Kerrigan, J.; Geoffroy, G.; Mandelbaum, D.; Jacobs, T.; Mesenbrink, P.; Kramer, L.; D'Souza, J. Neurology, 2000, 54, 2237.
265. Glauser, T.A. Pharmacotherapy, 2001, 21, 904.
266. Rattya, J.; Turkka, J.; Pakarinen, A.J.; Knip, M.; Kotila, M.A.; Lukkarinen, O.; Myllyla, V.V.; Isojarvi, J.I. Neurology, 2001, 56, 31.
267. Borusiak, P.; Korn-Meker, E.; Holert, N.; Boenigk, H.E. Epilepsy Res., 1998, 30, 241.
268. Baruzzi, A.; Albani, F.; Riva, R. Epilepsia, 1994, 35, 14.
269. Trileptal®: Prescribing information. Available from URL: http://www.pharma.us.novartis.com/product/pi/pdf/trileptal.pdf [Accessed on June 21, 2008]
270. de Sousa, M.; do Nascimento, F.; Martins, D.; Leite, I.; Cunha, A.; de Lima, G.; Evanir, F.; Frota, F.; de Moraes, O.; de Moraes, A. J. Pharmaceut. Biomed., 2007, 45, 304.
271. Mazzucchelli, I.; Franco, V.; Fattore, C.; Marchiselli, R.; Perucca, E.; Gatti, G. Ther. Drug Monit., 2007, 29, 319.
272. Ma, C.; Jiao, Z.; Jie, Y.; Shi, X. Chromatographia, 2007, 65, 267.
273. Kimiskidis, V.; Spanakis, M.; Niopas, I.; Kazis, D.; Gabrieli, C.; Kanaze, F.I.; Divanoglou, D. J. Pharmaceut. Biomed., 2007, 43, 763.
274. Nirogi, R.; Kandikere, V.; Shukla, M., Mudigonda, K.; Ajjala, D. Arzneimittel Forschung, 2006, 56, 517.
275. Contin, M.; Balboni, M.; Callegati, E.; Candela, C.; Albani, F.; Riva, R.; Baruzzi, A. J. Chromatogr. B, 2005, 828, 113.
276. Franceschi, L.; Furlanut, M. Pharmacol. Res., 2005, 51, 297.
277. Flesch, G.; Tudor, D.; Denouel, J.; Bonner, J.; Camisasca, R. Int. J. Clin. Pharm. Th., 2003, 41, 299.
278. Mandrioli, R.; Ghedini, N.; Albani, F.; Kenndler, E.; Raggi, M.A. J. Chromatogr. B, 2003, 783, 253.
279. Bugamelli, F.; Sabbioni, C.; Mandrioli, R.; Kenndler, E.; Albani, F.; Raggi, M.A. Anal. Chim. Acta, 2002, 472, 1.
280. Souppart, C.; Decherf, M.; Humbert, H.; Maurer, G. J. Chromatogr. B, 2001, 762, 9.
281. Matar, K.M.; Nicholls, P.J.; Bawazir, S.A.; Al-Hassan, M.I.; Tekle, A. Pharmaceutica Acta Helvetiae, 1999, 73, 247.
282. Vermeij, T.A.C.; Edelbroek, P.M. J. Chromatogr. B, 2007, 857, 40.
283. Greiner-Sosanko, E.; Giannoutsos, S.; Lower, D.R.; Virji, M.A.; Krasowski, M.D. J. Chromatogr. Sci., 2007, 45, 616.
284. Jones, M.D.; Ryan, M.; Miles, M.; Tang, P.H.; Fakhoury, T.; De Grauw, T.J.; Baumann, R. Ther. Drug Monit., 2005, 27, 576.
285. Miles, M.V.; Tang, P.H.; Ryan, M.A.; Grim, S.A.; Fakhoury, T.A.; Strawsburg, R.H.; DeGrauw, T.J.; Baumann, R.J. Ther. Drug Monit., 2004, 26, 300.
286. Kristensen, O.; Klitgaard, N.A.; Jonsson, B.; Sindrup, S. Acta Neurologica Scandinavica, 1983, 68, 145.
287. Volosov, A.; Yagen, B.; Bialer, M. Epilepsia, 2000, 41, 1107.
288. Volosov, A.; Xiaodong, S.; Perucca, E., Yagen, B.; Sintov, A., Bialer, M. Clin. Pharmacol. Ther., 1999, 66, 547.
289. Pucci, V.; Kenndler, E.; Raggi, M.A. Biomed. Chromatogr., 2003, 17, 231.
290. Saracino, M.A.; Girardi, P.; Mercolini, L.; Tallarico, K.; Koukopoulos, A.; Sani, G.; Raggi, M.A. Analysis of oxcarbazepine and metabolites in plasma and saliva of bipolar patients by MEPS-HPLC, TDM 2008, International Meeting on Therapeutic and Toxic effects of Central Nervous System drugs: The importance of drug monitoring, Bologna, October 2-3, 2008. Abstract book p. 113.